These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 9787282)
1. New drugs for Alzheimer's disease. Delagarza VW Am Fam Physician; 1998 Oct; 58(5):1175-82. PubMed ID: 9787282 [TBL] [Abstract][Full Text] [Related]
2. Pharmacologic treatment of Alzheimer's disease: an update. DeLaGarza VW Am Fam Physician; 2003 Oct; 68(7):1365-72. PubMed ID: 14567491 [TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington. Davis KL Geriatrics; 1999 Feb; 54(2):42-7; quiz 48. PubMed ID: 10024872 [TBL] [Abstract][Full Text] [Related]
4. Advances in the treatment of Alzheimer's disease. Sloane PD Am Fam Physician; 1998 Nov; 58(7):1577-86, 1589-90. PubMed ID: 9824956 [TBL] [Abstract][Full Text] [Related]
5. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
6. Pharmacologic approaches to cognitive deficits in Alzheimer's disease. Peskind ER J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483 [TBL] [Abstract][Full Text] [Related]
7. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council. Fillit H; Cummings J Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691 [TBL] [Abstract][Full Text] [Related]
8. Advances in the treatment of Alzheimer's disease. Schneider LS Aging (Milano); 1998 Apr; 10(2):156-7. PubMed ID: 9666210 [No Abstract] [Full Text] [Related]
9. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention. Beier MT Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151 [TBL] [Abstract][Full Text] [Related]
10. Galantamine: new preparation. The fourth cholinesterase inhibitor for Alzheimer's disease. Prescrire Int; 2001 Dec; 10(56):180-1. PubMed ID: 11824442 [TBL] [Abstract][Full Text] [Related]
12. The new approach in development of anti-Alzheimer's disease drugs via the cholinergic hypothesis. Sugimoto H Chem Biol Interact; 2008 Sep; 175(1-3):204-8. PubMed ID: 18577377 [TBL] [Abstract][Full Text] [Related]
13. [Alzheimer's disease: from brain lesions to new drugs]. Forette F; Hauw JJ Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689 [TBL] [Abstract][Full Text] [Related]
14. On the horizon: pathways for drug development in Alzheimer's disease. Hake AM; Farlow MR Clin Geriatr Med; 2004 Feb; 20(1):141-52. PubMed ID: 15062492 [No Abstract] [Full Text] [Related]
17. Maximizing function in Alzheimer's disease: what role for tacrine? Smucker WD Am Fam Physician; 1996 Aug; 54(2):645-52. PubMed ID: 8701842 [TBL] [Abstract][Full Text] [Related]